Iright
BRAND / VENDOR: Biolegend

Biolegend, 400606, FITC Rat IgG2b, κ Isotype Ctrl Antibody, 200μg

CATALOG NUMBER: 400606
Regular price$0.99
/
Shipping calculated at checkout.
  • In stock, ready to ship

  • Backordered, shipping soon

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.

Product Description

The isotype of RTK4530 immunoglobulin is rat IgG2b, κ. This antibody was chosen as an isotype control after screening on a variety of resting, activated, live, and fixed mouse, rat and human tissues.
200μg
Antibody Type: Monoclonal
Host Species: Rat
Immunogen: Trinitrophenol + KLH
Formulation: test sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).µg sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The immunoglobulin was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration: test sizes: lot-specific; µg sizes: 0.5 mg/ml
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested ICFC - Verified
Recommended Usage: Each lot of this rat IgG2b, ? isotype control antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, use the isotype control at the same concentration as your primary antibody. Use our Concentration Lookup tool to find the exact concentrations of your lots of product.
Excitation Laser: Blue Laser (488 nm)
Application Notes: The RTK4530 immunoglobulin is useful as an isotype-matched control (for the relevant formats) for Western blotting, immunoprecipitation, immunohistochemistry, functional assay, and immunofluorescence microscopy. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 400643, 400644, 400671, 400672, 400675, and 400676) as negative control.
Application References(PubMed link indicates BioLegend citation): Cervantes-Barragan L, et al. 2007. Blood 109:1131. Zeiser R, et al. 2007. Blood 109:2225. Sasaki K, et al. 2008. J. Immunol. 181:104. PubMed Duan J, et al. 2008. P. Natl. Acad. Sci. USA 105:5183. PubMed Yi H, et al. 2009. Blood 113:5819. PubMed Schafeer JS, et al. 2010. J. Leukocyte Biol. 87:301. PubMed Lei GS, et al. 2015. Infect Immun. 83:572. PubMed Richards J, et al. 2015. Mol Cell Cardiol. 79:21. PubMed
Product Citations: Elbasiony E, et al. 2023. NPJ Aging. 9:2. PubMed Pioli KT, et al. 2023. iScience. 26:106223. PubMed Dona MSI, et al. 2023. Basic Res Cardiol. 118:11. PubMed Kase N, et al. 2023. Front Cell Dev Biol. 11:1022081. PubMed Ding L, et al. 2023. J Clin Invest. 133: . PubMed Ye B, et al. 2022. Cell Mol Immunol. 19:619. PubMed Chen X, et al. 2021. Theranostics. 11:4655. PubMed Sakamoto T, et al. 2021. Commun Biol. 4:1165. PubMed Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed Tanner MA, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H633. PubMed Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed Reynolds A, et al. 2015. J Immunol. 194:231. PubMed Colliou N, et al. 2018. Gut Microbes. 9:279. PubMed Yuan F, et al. 2022. Front Immunol. 13:798583. PubMed Garg M, et al. 2021. Cell Reports. 34(6):108736. PubMed O'Connor T, et al. 2020. Cancer Cell. 36(3):250-267. PubMed Shiraki N, et al. 2022. Stem Cell Reports. 17:221. PubMed Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed Wang X, et al. 2018. Cell Death Dis. 9:578. PubMed Yang B, et al. 2022. Bioengineered. 13:2685. PubMed López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed Li J, et al. 2022. Nat Commun. 13:4032. PubMed Niemi JP, et al. 2020. Methods Mol Biol. 2143:207. PubMed Kumagai S, et al. 2020. Immunity. 53(1):187-203.e8. PubMed Wang S, et al. 2021. Parasite. 28:13. PubMed Ohgomori T et al. 2019. J Comp Neurol. 528(1):14-31 . PubMed Wang Y, et al. 2022. Front Immunol. 13:847581. PubMed Wang F, et al. 2018. Oncogene. 37:286. PubMed Grisanti LA, et al. 2019. JCI Insight. 5. PubMed Hao T, et al. 2019. Nat Commun. 10:3665. PubMed Patel C, et al. 2022. Curr Protoc. 2:e400. PubMed Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed Gupta P, et al. 2016. PLoS One. 11: 0154725. PubMed Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed Wu KKL, et al. 2021. Nat Commun. 12:6637. PubMed
RRID: AB_893678 (BioLegend Cat. No. 400633) AB_326549 (BioLegend Cat. No. 400605) AB_893662 (BioLegend Cat. No. 400634) AB_326550 (BioLegend Cat. No. 400606)
Gene ID: NA
Clone: RTK4530
Regulatory Status: RUO
Isotype: Rat IgG2b, κ


Order Guidelines

1. Price & Stock Available on Request. 📧Click to send email to: service@iright.com

2. Please DO NOT make payment before confirmation.

3. Minimum order value of $1,000 USD required.

Collaboration

Tony Tang

📧Email: Tony.Tang@iright.com

📱Mobile/WhatsApp/Wechat: +86-17717886924